In the current research, a higher NR2F6 expression was confirmed in hepatoblastoma than non-cancer liver with a combination of RNA-seq and microarrays samples, including 219 hepatoblastoma tissues and 121 non-cancer liver tissues (SMD = 1.04; 95% CI: 0.79, 1.29). Here, NR2F6 is linked to hepatoblastoma.